- Home
- EU vs PGEN Comparison
EU vs PGEN Comparison
Compare EU & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EU
- PGEN
- Stock Information
- Founded
- EU 2009
- PGEN 1998
- Country
- EU United States
- PGEN United States
- Employees
- EU N/A
- PGEN N/A
- Industry
- EU Other Metals and Minerals
- PGEN Biotechnology: Pharmaceutical Preparations
- Sector
- EU Basic Materials
- PGEN Health Care
- Exchange
- EU Nasdaq
- PGEN Nasdaq
- Market Cap
- EU 445.3M
- PGEN 493.0M
- IPO Year
- EU N/A
- PGEN N/A
- Fundamental
- Price
- EU $2.58
- PGEN $3.82
- Analyst Decision
- EU Strong Buy
- PGEN Buy
- Analyst Count
- EU 1
- PGEN 5
- Target Price
- EU $4.00
- PGEN $7.50
- AVG Volume (30 Days)
- EU 5.2M
- PGEN 9.2M
- Earning Date
- EU 11-13-2025
- PGEN 11-13-2025
- Dividend Yield
- EU N/A
- PGEN N/A
- EPS Growth
- EU N/A
- PGEN N/A
- EPS
- EU N/A
- PGEN N/A
- Revenue
- EU $44,524,000.00
- PGEN $4,340,000.00
- Revenue This Year
- EU $33.35
- PGEN $253.63
- Revenue Next Year
- EU $112.45
- PGEN $699.64
- P/E Ratio
- EU N/A
- PGEN N/A
- Revenue Growth
- EU N/A
- PGEN N/A
- 52 Week Low
- EU $1.01
- PGEN $0.65
- 52 Week High
- EU $4.44
- PGEN $5.23
- Technical
- Relative Strength Index (RSI)
- EU 56.05
- PGEN 54.30
- Support Level
- EU $2.21
- PGEN $3.47
- Resistance Level
- EU $2.37
- PGEN $4.14
- Average True Range (ATR)
- EU 0.13
- PGEN 0.35
- MACD
- EU 0.04
- PGEN -0.16
- Stochastic Oscillator
- EU 87.06
- PGEN 19.89
About EU enCore Energy Corp.
enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties of uranium resource properties in the United States. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's Projects are South Texas Operations, Dewey-Burdock Project, Gas Hills Project, Crownpoint & Hosta Butte Project, PFN (Prompt Fission Neutron) Technology, and Other Assets.
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.